Published in Arch Neurol on September 01, 1968
Neurological involvement in legionellosis. J Neurol Neurosurg Psychiatry (1982) 1.09
Pathology of ther peripheral nerves in leprosy: report of a case. J Neurol Neurosurg Psychiatry (1970) 0.92
The neuropathies of leprosy. West J Med (1980) 0.75
Alzheimer's disease and its Lewy body variant: a clinical analysis of postmortem verified cases. Am J Psychiatry (1996) 2.30
Ring finger testing in carpal tunnel syndrome: a comparative study of diagnostic utility. Muscle Nerve (1989) 2.21
Neurolymphomatosis: a clinicopathologic syndrome re-emerges. Neurology (1992) 2.14
Distant effects of local injection of botulinum toxin. Muscle Nerve (1987) 2.02
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology (1994) 2.00
Multifocal motor neuropathy with conduction block: is it a distinct clinical entity? Neurology (1992) 1.93
Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm. Mov Disord (1987) 1.92
Distant effects of locally injected botulinum toxin: a double-blind study of single fiber EMG changes. Muscle Nerve (1991) 1.77
Vasoactive intestinal polypeptide: abundant immunoreactivity in neural cell lines and normal nervous tissue. Science (1976) 1.76
Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm. Adv Neurol (1988) 1.72
"Maximal" thymectomy for myasthenia gravis. Results. J Thorac Cardiovasc Surg (1988) 1.63
Motor neuron disease and amyotrophic lateral sclerosis: relation of high CSF protein content to paraproteinemia and clinical syndromes. Neurology (1990) 1.61
DNA-triplet repeats and neurologic disease. N Engl J Med (1996) 1.60
Competent patients with advanced states of permanent paralysis have the right to forgo life-sustaining therapy. Neurology (1993) 1.58
Lymphoproliferative disorders and motor neuron disease: an update. Neurology (1997) 1.54
Polyglucosan body disease. Muscle Nerve (1991) 1.50
Familial opticoacoustic nerve degeneration and polyneuropathy. Neurology (1967) 1.50
A clinical and genetic study of chronic proximal spinal muscular atrophy. Brain (1975) 1.48
Category fluency in mild cognitive impairment: reduced effect of practice in test-retest conditions. Alzheimer Dis Assoc Disord (2004) 1.48
Two novel pathogenic mitochondrial DNA mutations affecting organelle number and protein synthesis. Is the tRNA(Leu(UUR)) gene an etiologic hot spot? J Clin Invest (1993) 1.48
Prognosis of ocular myasthenia. Ann Neurol (1983) 1.35
Botulinum toxin (BOTOX) for the treatment of "spastic dysphonia" as part of a trial of toxin injections for the treatment of other cranial dystonias. Laryngoscope (1986) 1.33
Peripheral neuropathy and starvation after gastric partitioning for morbid obesity. Ann Intern Med (1982) 1.31
A rational approach to total thymectomy in the treatment of myasthenia gravis. Ann Thorac Surg (1977) 1.28
Correlation of double-minute chromosomes with unstable multidrug cross-resistance in uptake mutants of neuroblastoma cells. Proc Natl Acad Sci U S A (1981) 1.28
Autosomal dominant striatonigral degeneration. A clinical, pathologic, and biochemical study of a new genetic disorder. Neurology (1976) 1.27
Markers for gene expression in cultured cells from the nervous system. J Biol Chem (1972) 1.26
Transverse myelitis associated with heroin addiction. JAMA (1968) 1.22
The prognosis of acute polyradiculoneuritis. Neurology (1968) 1.22
The sympathetic skin response: normal values, elucidation of afferent components and application limits. J Neurol Sci (1988) 1.22
Autosomal dominant cerebellar phenotypes: the genotype has settled the issue. Neurology (1995) 1.21
Effects of practice on category fluency in Alzheimer's disease. Clin Neuropsychol (2001) 1.20
Peripheral neuropathy in long-term diphenylhydantoin therapy. Arch Neurol (1968) 1.18
Autogenous vein graft as a conduit for nerve regeneration. Surgery (1982) 1.18
Apoptosis and neurologic disease. Am J Med (2000) 1.17
Hyperkalemic periodic paralysis. Arch Neurol (1967) 1.17
Relation of abnormal folate metabolism to neuropathy developing during anticonvulsant drug therapy. Lancet (1968) 1.14
Localized injections of botulinum toxin for the treatment of focal laryngeal dystonia (spastic dysphonia). Laryngoscope (1988) 1.14
Moebius syndrome in Kallmann syndrome. Arch Neurol (1975) 1.09
Neurologic involvement in Urbach-Wiethe's disease (lipoid proteinosis). A clinical, ultrastructural, and chemical study. Neurology (1971) 1.07
Tomaculous neuropathy in chromosome 1 Charcot-Marie-Tooth syndrome. Acta Neuropathol (1994) 1.03
Platelet APP isoform ratios correlate with declining cognition in AD. Neurology (2000) 1.01
Olivopontocerebellar degeneration. Clinical and ultrastructural abnormalities. Arch Neurol (1974) 1.01
Clinical and electrodiagnostic features of Charcot-Marie-Tooth syndrome. Acta Neurol Scand Suppl (1978) 1.01
Inclusion body myositis mimicking motor neuron disease. Arch Neurol (2001) 1.01
Comparison of the hopkins verbal learning test-revised to the California verbal learning test in Alzheimer's disease. Appl Neuropsychol (2001) 1.00
Adductor laryngeal dystonia (spastic dysphonia): treatment with local injections of botulinum toxin (Botox). Mov Disord (1989) 0.99
Neurological complications of fibrous dysplasia of the skull. Arch Neurol (1968) 0.99
Joseph's disease: an autosomal dominant neurological disease in the Portuguese of the United States and the Azores Islands. Adv Neurol (1978) 0.97
The natural history of Machado-Joseph disease. An analysis of 138 personally examined cases. Can J Neurol Sci (1984) 0.97
Creatine kinase BB isoenzyme levels by radioimmunoassay in patients with neurological disease. Ann Neurol (1978) 0.97
The clinical diagnosis of McArdle's disease. Identification of another family with deficiency of muscle phosphorylase. Neurology (1966) 0.96
Neuromuscular involvement in mild, asymptomatic primary hyperparathyroidism. Am J Med (1989) 0.96
Antibodies to acetylcholine receptors in rabbits: immunochemical and electrophysiological studies. Ann N Y Acad Sci (1976) 0.94
Glial tumor metastases through a ventriculo-pleural shunt. Resultant massive pleural effusion. Arch Neurol (1968) 0.94
The Machado-Joseph disease locus is different from the spinocerebellar ataxia locus (SCA1). Genomics (1992) 0.94
Electrophysiologic features of abetalipoproteinemia: functional consequences of vitamin E deficiency. Neurology (1986) 0.94
Clinical and laboratory characteristics of focal laryngeal dystonia: study of 110 cases. Laryngoscope (1988) 0.93
Seronegative myasthenia gravis. Neurology (1988) 0.93
Electrophysiologic correlates of peripheral nervous system maturation in infancy and childhood. J Child Neurol (1993) 0.93
Vasoactive intestinal polypeptide in brain synaptosomes. Lancet (1976) 0.91
Apolipoprotein E epsilon 4, other risk factors, and course of Alzheimer's disease. Biol Psychiatry (1999) 0.91
Progressive ophthalmoplegia. Report of cases. Arch Neurol (1968) 0.90
Joseph disease: an autosomal dominant motor system degeneration. Adv Neurol (1984) 0.90
Prion proteins: a biological role beyond prion diseases. Acta Neurol Scand (2007) 0.90
Sensory conduction in peroneal, posterior tibial and sural nerves using averaging techniques. Electroencephalogr Clin Neurophysiol (1969) 0.89
Differences in the distribution of poly(A) size classes in individual messenger RNAs from neuroblastoma cells. J Biol Chem (1979) 0.89
Electromyographic findings in focal laryngeal dystonia (spastic dysphonia). Ann Otol Rhinol Laryngol (1986) 0.88
Physiology of glia: glial-neuronal interactions. Int Rev Neurobiol (1979) 0.88
Spastic paraplegia-paraparesis. A reappraisal. J Neurol Sci (1980) 0.88
Anti-MAG and anti-SGPG antibodies in neuropathy. Muscle Nerve (1996) 0.87
Frontal lobe ataxia. Surg Neurol (1995) 0.87
Experimental chemotherapy of neuroblastoma. II. Increased thymidylate synthetase activity in a 5-fluorodeoxyuridine-resistant variant of mouse neuroblastoma. Mol Pharmacol (1975) 0.86
Slow motor nerve conduction in myotonic dystrophy. Electromyogr Clin Neurophysiol (1981) 0.86
Motor neuron disease and plasma cell dyscrasia. Neurology (1986) 0.86
A radioisotopic, chromatographic microassay for acetyl-coenzyme A synthetase and some preliminary studies on the rat brain enzyme. Biochim Biophys Acta (1973) 0.85
Correlation of statin-increased platelet APP ratios and reduced blood lipids in AD patients. Neurology (2003) 0.85
Sensory conduction in peroneal and posterior tibial nerves using averaging techniques. J Neurol Neurosurg Psychiatry (1973) 0.84
Autosomal dominant progressive syndrome of motor-speech loss without dementia. Neurology (1997) 0.84
Central core disease with congenital hip dislocation: study of two families. Neurology (1971) 0.84
Induction of adenosine 3',5'-monophosphate binding proteins by N6,O2'-dibutyryladenosine 3',5'-monophosphate in mouse neuroblastoma cells. Analysis by two-dimensional gel electrophoresis. Biochemistry (1979) 0.84
Altered apolipoprotein E secretion in cytokine treated human astrocyte cultures. J Neurol Sci (1997) 0.84
Long-duration polyphasic motor unit potentials in myopathies: a quantitative study with pathological correlation. Muscle Nerve (1990) 0.83
Serum antibodies to cytomegalovirus in myasthenia gravis: effects of thymectomy and steroids. Neurology (1978) 0.83
Glutamate and malate dehydrogenase activities in Joseph disease and olivopontocerebellar atrophy. Neurology (1987) 0.83
Comparative electrophysiologic evaluation of nerve grafts and autogenous vein grafts as nerve conduits: an experimental study. J Reconstr Microsurg (1988) 0.83
Machado Joseph disease maps to the same region of chromosome 14 as the spinocerebellar ataxia type 3 locus. J Med Genet (1995) 0.82
Specific messenger RNA changes in Joseph disease cerebella. Ann Neurol (1983) 0.82
Regulation of the synthesis of choline-O-acetyltransferase and thymidylate synthetase in mouse neuroblastoma in cell culture. Proc Natl Acad Sci U S A (1971) 0.82
Reye's syndrome: isolation of parainfluenza virus. Report of three cases. Arch Neurol (1973) 0.81
A comparison of thymidylate synthetase activities from 5-fluorodeoxyuridine sensitive and resistant variants of mouse neuroblastoma. J Neurochem (1975) 0.81
Altered thymidine kinase or thymidylate synthetase activities in 5-fluoro deoxyuridine resistant variants of mouse neuroblastoma. J Neurochem (1977) 0.81
Quantitation and characterisation of poly(A)-containing messenger RNAs from mouse neuroblastoma cells. Biochim Biophys Acta (1977) 0.81
Hypothermia and persisting capacity to develop fever. Occurrence in a patient with sarcoidosis of the central nervous system. Arch Neurol (1977) 0.81
Peripheral neuropathy associated with plasma cell dyscrasia: a clinical and electrophysiological follow-up study. Acta Neurol Scand (1987) 0.81
Furosemide-sensitive K+ channel in glioma cells but not neuroblastoma cells in culture. Biochem Biophys Res Commun (1982) 0.81
Idiopathic polyneuropathy associated with cytotoxic anti-neuroblastoma serum. IgG and IgM immunoglobulin studies. Neurology (1975) 0.81
Vasculitic neuropathy in a patient with cryoglobulinemia and anti-MAG IGM monoclonal gammopathy. Muscle Nerve (1992) 0.80
Induction of cyclic AMP-binding proteins by dibutyryl cyclic AMP in mouse neuroblastoma cells. Biochim Biophys Acta (1978) 0.80